CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis

NYSE:CX • US1512908898

12.57 USD
+0.07 (+0.56%)
At close: Feb 18, 2026
12.56 USD
-0.01 (-0.08%)
After Hours: 2/18/2026, 8:23:35 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CX. CX was compared to 13 industry peers in the Construction Materials industry. CX has a medium profitability rating, but doesn't score so well on its financial health evaluation. CX is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CX was profitable.
  • CX had a positive operating cash flow in the past year.
  • Of the past 5 years CX 4 years were profitable.
  • Of the past 5 years CX 4 years had a positive operating cash flow.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

  • The Return On Assets of CX (4.70%) is worse than 61.54% of its industry peers.
  • CX has a Return On Equity (10.03%) which is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 5.31%, CX is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for CX is below the industry average of 9.05%.
Industry RankSector Rank
ROA 4.7%
ROE 10.03%
ROIC 5.31%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

  • CX's Profit Margin of 8.62% is on the low side compared to the rest of the industry. CX is outperformed by 61.54% of its industry peers.
  • CX's Profit Margin has improved in the last couple of years.
  • CX has a worse Operating Margin (9.55%) than 76.92% of its industry peers.
  • CX's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 32.75%, CX is doing good in the industry, outperforming 69.23% of the companies in the same industry.
  • CX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.55%
PM (TTM) 8.62%
GM 32.75%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CX is destroying value.
  • CX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • CX has an Altman-Z score of 1.71. This is a bad value and indicates that CX is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CX (1.71) is comparable to the rest of the industry.
  • The Debt to FCF ratio of CX is 12.73, which is on the high side as it means it would take CX, 12.73 years of fcf income to pay off all of its debts.
  • CX's Debt to FCF ratio of 12.73 is in line compared to the rest of the industry. CX outperforms 46.15% of its industry peers.
  • A Debt/Equity ratio of 0.44 indicates that CX is not too dependend on debt financing.
  • CX's Debt to Equity ratio of 0.44 is fine compared to the rest of the industry. CX outperforms 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 12.73
Altman-Z 1.71
ROIC/WACC0.36
WACC14.56%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 0.91 indicates that CX may have some problems paying its short term obligations.
  • The Current ratio of CX (0.91) is worse than 84.62% of its industry peers.
  • CX has a Quick Ratio of 0.91. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.67, CX is doing worse than 76.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.67
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • CX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.49%.
  • The Earnings Per Share has been growing by 14.77% on average over the past years. This is quite good.
EPS 1Y (TTM)-85.49%
EPS 3Y14.77%
EPS 5YN/A
EPS Q2Q%-433.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.66%

3.2 Future

  • The Earnings Per Share is expected to grow by 91.80% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CX will show a small growth in Revenue. The Revenue will grow by 5.90% on average per year.
EPS Next Y231.07%
EPS Next 2Y91.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.11%
Revenue Next 2Y4.76%
Revenue Next 3Y7.87%
Revenue Next 5Y5.9%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.96, which indicates a correct valuation of CX.
  • Based on the Price/Earnings ratio, CX is valued cheaper than 92.31% of the companies in the same industry.
  • CX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.27.
  • Based on the Price/Forward Earnings ratio of 4.52, the valuation of CX can be described as very cheap.
  • CX's Price/Forward Earnings ratio is rather cheap when compared to the industry. CX is cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.16. CX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.96
Fwd PE 4.52
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CX is cheaper than 100.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CX is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 34.19
EV/EBITDA 8.35
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CX's earnings are expected to grow with 91.80% in the coming years.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y91.8%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 20.96%, CX is a good candidate for dividend investing.
  • CX's Dividend Yield is rather good when compared to the industry average which is at 2.07. CX pays more dividend than 100.00% of the companies in the same industry.
  • CX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 20.96%

5.2 History

  • CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • CX pays out 9.12% of its income as dividend. This is a sustainable payout ratio.
DP9.12%
EPS Next 2Y91.8%
EPS Next 3YN/A
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B
CX Dividend Payout.CX Dividend Payout, showing the Payout Ratio.CX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (2/18/2026, 8:23:35 PM)

After market: 12.56 -0.01 (-0.08%)

12.57

+0.07 (+0.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-05
Earnings (Next)04-23
Inst Owners25.28%
Inst Owner Change-0.88%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.24B
Revenue(TTM)N/A
Net Income(TTM)1.36B
Analysts78.67
Price Target12.86 (2.31%)
Short Float %0.81%
Short Ratio1.84
Dividend
Industry RankSector Rank
Dividend Yield 20.96%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP9.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.04%
Min EPS beat(2)-51.46%
Max EPS beat(2)-12.62%
EPS beat(4)0
Avg EPS beat(4)-38.83%
Min EPS beat(4)-88.35%
Max EPS beat(4)-2.91%
EPS beat(8)1
Avg EPS beat(8)144.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.88%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-1.61%
Revenue beat(4)0
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)-1.61%
Revenue beat(8)0
Avg Revenue beat(8)-4.48%
Revenue beat(12)1
Avg Revenue beat(12)-3.51%
Revenue beat(16)2
Avg Revenue beat(16)1.69%
PT rev (1m)8.57%
PT rev (3m)24.96%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.95%
Revenue NQ rev (1m)-5.18%
Revenue NQ rev (3m)-11.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE 14.96
Fwd PE 4.52
P/S 1.15
P/FCF 34.19
P/OCF 8.93
P/B 1.34
P/tB 4.54
EV/EBITDA 8.35
EPS(TTM)0.84
EY6.68%
EPS(NY)2.78
Fwd EY22.12%
FCF(TTM)0.37
FCFY2.92%
OCF(TTM)1.41
OCFY11.2%
SpS10.91
BVpS9.38
TBVpS2.77
PEG (NY)0.06
PEG (5Y)N/A
Graham Number13.31
Profitability
Industry RankSector Rank
ROA 4.7%
ROE 10.03%
ROCE 6.73%
ROIC 5.31%
ROICexc 5.67%
ROICexgc 10.4%
OM 9.55%
PM (TTM) 8.62%
GM 32.75%
FCFM 3.37%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
ROICexc(3y)7.18%
ROICexc(5y)6.61%
ROICexgc(3y)13.44%
ROICexgc(5y)12.5%
ROCE(3y)8.62%
ROCE(5y)7.97%
ROICexgc growth 3Y3.59%
ROICexgc growth 5Y8.98%
ROICexc growth 3Y3.55%
ROICexc growth 5Y10.09%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 12.73
Debt/EBITDA 2.16
Cap/Depr 117.98%
Cap/Sales 9.53%
Interest Coverage 250
Cash Conversion 73.17%
Profit Quality 39.1%
Current Ratio 0.91
Quick Ratio 0.67
Altman-Z 1.71
F-Score5
WACC14.56%
ROIC/WACC0.36
Cap/Depr(3y)98.23%
Cap/Depr(5y)87.02%
Cap/Sales(3y)7.21%
Cap/Sales(5y)6.61%
Profit Quality(3y)217.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.49%
EPS 3Y14.77%
EPS 5YN/A
EPS Q2Q%-433.33%
EPS Next Y231.07%
EPS Next 2Y91.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.66%
Revenue Next Year5.11%
Revenue Next 2Y4.76%
Revenue Next 3Y7.87%
Revenue Next 5Y5.9%
EBIT growth 1Y-29.96%
EBIT growth 3Y2.07%
EBIT growth 5Y6.6%
EBIT Next Year60.32%
EBIT Next 3Y22.39%
EBIT Next 5YN/A
FCF growth 1Y-51.1%
FCF growth 3Y-11.58%
FCF growth 5Y-3.16%
OCF growth 1Y-17.47%
OCF growth 3Y0.91%
OCF growth 5Y6.96%

CEMEX SAB-SPONS ADR PART CER / CX FAQ

What is the ChartMill fundamental rating of CEMEX SAB-SPONS ADR PART CER (CX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CX.


What is the valuation status for CX stock?

ChartMill assigns a valuation rating of 8 / 10 to CEMEX SAB-SPONS ADR PART CER (CX). This can be considered as Undervalued.


What is the profitability of CX stock?

CEMEX SAB-SPONS ADR PART CER (CX) has a profitability rating of 4 / 10.


Can you provide the financial health for CX stock?

The financial health rating of CEMEX SAB-SPONS ADR PART CER (CX) is 2 / 10.


How sustainable is the dividend of CEMEX SAB-SPONS ADR PART CER (CX) stock?

The dividend rating of CEMEX SAB-SPONS ADR PART CER (CX) is 6 / 10 and the dividend payout ratio is 9.12%.